SIP
OFIX icon

Stoneridge Investment Partners’s Orthofix Medical OFIX Stock Holding History

Stoneridge Investment Partners’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-16,531
Closed -$377K – 221
2013
Q4 		$377K Sell
16,531
-100
-0.6% -$2.09K 0.07% 141
2013
Q3 		$345K Buy
16,631
+3,300
+25% +$80.1K 0.08% 142
2013
Q2 		$359K Buy
+13,331
New +$399K 0.08% 113

Other funds holding OFIX

NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Stoneridge Investment Partners's OFIX Position: Q1 2014 in Review

Stoneridge Investment Partners sold out of Orthofix Medical (OFIX) in Q1 2014, closing a stake of 16,531 shares — an estimated $377K sold.

Stoneridge Investment Partners first reported a position in OFIX in Q2 2013 and held it in 3 quarters. The position peaked at $377K in Q4 2013. 109 funds tracked by Wall St. Rank hold OFIX as of Q1 2014.

  • Stoneridge Investment Partners reported no remaining Orthofix Medical position as of Q1 2014 after selling out during the quarter.
  • Stoneridge Investment Partners sold 16,531 Orthofix Medical shares in Q1 2014, an estimated $377K.
  • Stoneridge Investment Partners first reported a position in Orthofix Medical in Q2 2013 and held it in 3 quarters.
  • Stoneridge Investment Partners's Orthofix Medical position peaked at $377K in Q4 2013.
  • 109 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2014.

Based on Stoneridge Investment Partners's 13F filing for Q1 2014, filed 15 Apr 2014.